週边血管设备市场规模、份额和成长分析（按类型、应用、最终用途和地区）- 产业预测 2025-2032

预计 2023 年周边血管设备市场规模将达到 84.9 亿美元，并将从 2024 年的 89.6 亿美元增长到 2032 年的 137.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.5%。

由于血管疾病发病率不断上升和人口老化，全球週边血管设备市场正在经历显着增长。糖尿病和肥胖症等与文明病的增加加剧了这一趋势，推动了对创新治疗方案的需求。这些设备有助于进行血管成形术和支架置入术等微创干预，从而提高患者的舒适度并缩短恢復时间。影像技术的进步和有利的报销政策进一步刺激了市场扩张，然而严格的法规和高成本等挑战仍然存在，尤其是在新兴市场。值得注意的趋势包括药物涂层球囊和生物可吸收支架的发展，以及对个人化医疗和数位健康解决方案的日益关注，旨在优化患者结果和提高治疗依从性。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

週边血管设备市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 外周支架
• PTA气球
• 栓塞保护装置
• 主动脉支架
• 人工外科植入物
• 慢性完全封堵装置
• 其他的

週边血管设备市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 周边动脉疾病(PAD)
• 动脉瘤
• 静脉疾病

週边血管设备市场规模（依最终用途及复合年增长率划分）（2025-2032）

• 市场概况
• 医院
• 门诊手术中心（ASC）
• 专科门诊
• 其他的

週边血管设备市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic plc（USA）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Becton, Dickinson and Company（USA）
• Koninklijke Philips NV（Netherlands）
• Cook Medical Inc.（USA）
• Terumo Corporation（Japan）
• Cardinal Health, Inc.（USA）
• B. Braun Melsungen AG（Germany）
• BIOTRONIK SE & Co. KG（Germany）
• WL Gore & Associates, Inc.（USA）
• Getinge AB（Sweden）
• MicroPort Scientific Corporation（China）
• CryoLife, Inc.（USA）
• Lombard Medical（UK）
• Merit Medical Systems, Inc.（USA）
• Edwards Lifesciences Corporation（USA）
• Nipro Corporation（Japan）
• Bluesail Medical Co., Ltd.（China）

结论和建议

Peripheral Vascular Devices Market size was valued at USD 8.49 billion in 2023 and is poised to grow from USD 8.96 billion in 2024 to USD 13.75 billion by 2032, growing at a CAGR of 5.5% during the forecast period (2025-2032).

The global Peripheral Vascular Devices Market is experiencing significant growth driven by the rising incidence of vascular diseases and an aging population. Increasing lifestyle-related conditions such as diabetes and obesity contribute to this trend, boosting the demand for innovative treatment solutions. These devices facilitate minimally invasive interventions like angioplasty and stenting, which enhance patient comfort and reduce recovery times. Advancements in imaging technologies and favorable reimbursement policies further stimulate market expansion, though challenges such as stringent regulations and high costs persist, particularly in emerging markets. Notable trends include the development of drug-coated balloons and bioresorbable stents, alongside a growing emphasis on personalized medicine and digital health solutions, which aim to optimize patient outcomes and improve adherence to treatment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Vascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Vascular Devices Market Segments Analysis

Global Peripheral Vascular Devices Market is segmented by Type, Application, End-Use and region. Based on Type, the market is segmented into Peripheral Stents, PTA Balloons,embolic protection devices, Aortic Stents, Synthetic Surgical Grafts, Chronic Total Occlusion Devices and Others. Based on Application, the market is segmented into Peripheral Arterial Disease (PAD), Aneurysms and Venous Diseases. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Vascular Devices Market

The peripheral vascular devices market is significantly influenced by the escalating incidence of cardiovascular conditions, including peripheral artery disease (PAD) and deep vein thrombosis (DVT). As reported by the World Health Organization (WHO), cardiovascular diseases rank as the primary cause of mortality globally. This rising prevalence not only underscores the urgent need for effective diagnostic and treatment solutions but also fosters an expanding demand for peripheral vascular devices. The ongoing health challenges presented by these conditions are driving advancements and innovations in this market, highlighting its critical role in enhancing patient outcomes and managing cardiovascular health.

Restraints in the Peripheral Vascular Devices Market

One of the major constraints facing the peripheral vascular devices market is the substantial cost linked to these products. The expenses stem from various factors, including extensive research and development expenditures, stringent regulatory compliance, and the incorporation of advanced materials and technologies. These high price tags can hinder the widespread adoption of these devices, especially in developing nations where healthcare budgets are constrained and reimbursement systems often pose challenges. Consequently, the financial burden associated with peripheral vascular devices may restrict their accessibility and utilization, limiting the market's growth potential.

Market Trends of the Peripheral Vascular Devices Market

The peripheral vascular devices market is witnessing a significant shift towards drug-eluting devices, reflecting a heightened demand for innovations that enhance patient outcomes. These advanced devices deliver targeted therapeutic agents directly to affected blood vessels, effectively mitigating the risk of restenosis and minimizing the necessity for repeated interventions. By utilizing drug-eluting stents that disperse anti-proliferative medications, this market trend not only improves long-term efficacy for patients but also aligns with the broader healthcare focus on personalized treatment approaches. As healthcare providers prioritize strategies that optimize recovery and reduce healthcare costs, the adoption of drug-eluting technologies is expected to accelerate in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Peripheral Vascular Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Peripheral Stents
• PTA Balloons
• Embolic Protection Devices
• Aortic Stents
• Synthetic Surgical Grafts
• Chronic Total Occlusion Devices
• Others

Global Peripheral Vascular Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Peripheral Arterial Disease (PAD)
• Aneurysms
• Venous Diseases

Global Peripheral Vascular Devices Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

Global Peripheral Vascular Devices Market Size & CAGR (2025-2032)

• North America (Type, Application, End-Use)
  • US
  • Canada
• Europe (Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bluesail Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations